This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vieweg, J. Articles by Gilboa, E. Search for Related Content PubMed PubMed Citation Articles by Vieweg, J. Articles by Gilboa, E.

Efficient Gene Transfer with Adeno-associated Virus-based Plasmids Complexed to Cationic Liposomes for Gene Therapy of Human Prostate Cancer¹

Department of Surgery, Division of Urology [J. V., K. M. R., D. W. E., C. R.], Division of Experimental Surgery [D. B., T. R., E. G.], Department of Medicine, Division of Hematological Oncology [C. S.], Duke University Medical Center, Durham, North Carolina 27710, and Applied Immune Sciences, Inc., Santa Clara, California 95054 [M. P., R. P.]

We have shown previously that treatment of rats bearing the Dunning R3327 MatLyLu prostatic tumor with human interleukin 2 (IL-2) gene-modified tumor cell preparations induces potent antitumor immunity in the animal. To test the clinical feasibility of using genetically modified tumor vaccines for the treatment of prostate cancer, we have explored the use of a simplified gene delivery system based on liposomes to introduce and express the IL-2 gene in the Dunning rat R3327 MatLyLu prostatic tumor cell line (MatLyLu) and in short-term cultures of primary human prostatic tumor cells. Liposome-DNA complexes containing the adeno-associated virus inverted terminal repeats exhibited 3–10-fold higher levels of gene transfer and IL-2 expression than did liposome complexes with non-adeno-associated virus containing plasmids. Single transfections resulted in IL-2 expression for an extended period of time that exceeded severalfold the amount of IL-2 secreted from retrovirally transduced MatLyLu cells. X-irradiation of cells (4000 rads) prior to transfection did not affect cytokine secretion, indicating that liposome-mediated gene transfer does not depend on cell proliferation. High levels of gene transfer and IL-2 expression were also achieved in short-term cultures of primary human prostatic tumor cells established from tumor specimens obtained following radical prostatectomy of cancer patients. Depending on the type of liposome used, IL-2 levels secreted from the human prostatic tumor cells were comparable to or exceeded the levels of IL-2 secreted from retrovirally transduced MatLyLu cells, which induced antitumor immunity in the rat model. The ability to culture and expand ex vivo human prostatic tumor cells, and the use of a simple and highly efficient gene transfer method to generate genetically modified tumor vaccines, set the stage for clinical exploration of gene-based immunotherapy of prostate cancer.

¹ This research was supported by SPORE Planning Grant CA 58192 and a CapCURE Foundation Award (E. G.).

² To whom requests for reprints should be addressed, at Duke University Medical Center, Box 3619, Durham, NC 27710.

Received 1/ 9/95. Accepted 3/28/95.

This article has been cited by other articles:

				D M Peehl Primary cell cultures as models of prostate cancer development Endocr. Relat. Cancer, March 1, 2005; 12(1): 19 - 47. [Abstract] [Full Text] [PDF]

				S. Ponnazhagan, D. T. Curiel, D. R. Shaw, R. D. Alvarez, and G. P. Siegal Adeno-associated Virus for Cancer Gene Therapy Cancer Res., September 1, 2001; 61(17): 6313 - 6321. [Full Text] [PDF]

				W. Satoh, Y. Hirai, K. Tamayose, and T. Shimada Site-Specific Integration of an Adeno-Associated Virus Vector Plasmid Mediated by Regulated Expression of Rep Based on Cre-loxP Recombination J. Virol., November 15, 2000; 74(22): 10631 - 10638. [Abstract] [Full Text]

				W. A. Larchian, Y. Horiguchi, S. K. Nair, W. R. Fair, W. D. W. Heston, and E. Gilboa Effectiveness of Combined Interleukin 2 and B7.1 Vaccination Strategy Is Dependent on the Sequence and Order: A Liposome-mediated Gene Therapy Treatment for Bladder Cancer Clin. Cancer Res., July 1, 2000; 6(7): 2913 - 2920. [Abstract] [Full Text]

				A. K. Malik, P. E. Monahan, D. L. Allen, B.-G. Chen, R. J. Samulski, and K. Kurachi Kinetics of Recombinant Adeno-Associated Virus-Mediated Gene Transfer J. Virol., April 15, 2000; 74(8): 3555 - 3565. [Abstract] [Full Text]

				X. Tang, D. Mohuczy, Y. C. Zhang, B. Kimura, S. M. Galli, and M. I. Phillips Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2392 - H2399. [Abstract] [Full Text] [PDF]

				D. Duan, P. Sharma, J. Yang, Y. Yue, L. Dudus, Y. Zhang, K. J. Fisher, and J. F. Engelhardt Circular Intermediates of Recombinant Adeno-Associated Virus Have Defined Structural Characteristics Responsible for Long-Term Episomal Persistence in Muscle Tissue J. Virol., November 1, 1998; 72(11): 8568 - 8577. [Abstract] [Full Text] [PDF]